Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W4235508058', 'doi': 'https://doi.org/10.2165/00128413-200716090-00020', 'title': 'Bortezomib appears to be useful in the management of chronic graft-versus-host disease (GVHD) in patients with multiple myeloma (MM)', 'display_name': 'Bortezomib appears to be useful in the management of chronic graft-versus-host disease (GVHD) in patients with multiple myeloma (MM)', 'publication_year': 2007, 'publication_date': '2007-10-01', 'ids': {'openalex': 'https://openalex.org/W4235508058', 'doi': 'https://doi.org/10.2165/00128413-200716090-00020'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.2165/00128413-200716090-00020', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S11454955', 'display_name': 'Inpharma Weekly', 'issn_l': '1173-8324', 'issn': ['1173-8324', '2230-6056'], 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/P4310319965', 'host_organization_name': 'Springer Nature', 'host_organization_lineage': ['https://openalex.org/P4310319965'], 'host_organization_lineage_names': ['Springer Nature'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A9999999999', 'display_name': 'NULL AUTHOR_ID', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': True, 'raw_author_name': 'None &NA;', 'raw_affiliation_strings': [], 'affiliations': []}], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': ['https://openalex.org/A9999999999'], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 63}, 'biblio': {'volume': '&NA;', 'issue': '1609', 'first_page': '10', 'last_page': '10'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10649', 'display_name': 'Diagnosis and Treatment of Multiple Myeloma', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10649', 'display_name': 'Diagnosis and Treatment of Multiple Myeloma', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11752', 'display_name': 'Chemotherapy-Induced Peripheral Neuropathy in Cancer Treatment', 'score': 0.9894, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12689', 'display_name': 'Silymarin in Liver Diseases and Cancer Treatment', 'score': 0.9298, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/international-myeloma-working-group', 'display_name': 'International Myeloma Working Group', 'score': 0.494003}], 'concepts': [{'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.9308013}, {'id': 'https://openalex.org/C2776364478', 'wikidata': 'https://www.wikidata.org/wiki/Q467635', 'display_name': 'Multiple myeloma', 'level': 2, 'score': 0.81290704}, {'id': 'https://openalex.org/C2777478702', 'wikidata': 'https://www.wikidata.org/wiki/Q419319', 'display_name': 'Bortezomib', 'level': 3, 'score': 0.8077006}, {'id': 'https://openalex.org/C2779972918', 'wikidata': 'https://www.wikidata.org/wiki/Q1194520', 'display_name': 'Graft-versus-host disease', 'level': 3, 'score': 0.73946077}, {'id': 'https://openalex.org/C104863432', 'wikidata': 'https://www.wikidata.org/wiki/Q614304', 'display_name': 'Pharmacy', 'level': 2, 'score': 0.44996402}, {'id': 'https://openalex.org/C126831891', 'wikidata': 'https://www.wikidata.org/wiki/Q221673', 'display_name': 'Host (biology)', 'level': 2, 'score': 0.4190029}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.4113769}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.4014387}, {'id': 'https://openalex.org/C2779134260', 'wikidata': 'https://www.wikidata.org/wiki/Q12136', 'display_name': 'Disease', 'level': 2, 'score': 0.3883541}, {'id': 'https://openalex.org/C512399662', 'wikidata': 'https://www.wikidata.org/wiki/Q3505712', 'display_name': 'Family medicine', 'level': 1, 'score': 0.07199532}, {'id': 'https://openalex.org/C18903297', 'wikidata': 'https://www.wikidata.org/wiki/Q7150', 'display_name': 'Ecology', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.2165/00128413-200716090-00020', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S11454955', 'display_name': 'Inpharma Weekly', 'issn_l': '1173-8324', 'issn': ['1173-8324', '2230-6056'], 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/P4310319965', 'host_organization_name': 'Springer Nature', 'host_organization_lineage': ['https://openalex.org/P4310319965'], 'host_organization_lineage_names': ['Springer Nature'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'score': 0.6, 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W3029266790', 'https://openalex.org/W3028919400', 'https://openalex.org/W2409439928', 'https://openalex.org/W2377458274', 'https://openalex.org/W2124503326', 'https://openalex.org/W2104965094', 'https://openalex.org/W2104706142', 'https://openalex.org/W2063424779', 'https://openalex.org/W2027348595', 'https://openalex.org/W1991948976'], 'abstract_inverted_index': None, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W4235508058', 'counts_by_year': [], 'updated_date': '2024-09-18T15:14:34.646363', 'created_date': '2022-05-12'}